Please assess the completion status of the following clinical trial:

Trial Title: Safety and Efficacy of Automatic Testing Feature in New ICDs and CRT-Ds

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Have an approved indication, as outlined by American Heart Association/Heart Rhythm Society (AHA/HRS) guidelines, for implantation of an ICD or CRT-D for the treatment of life-threatening ventricular tachyarrhythmia(s) or heart failure, or undergo revision of their ICD or CRT-D system to replace the pulse generator.~* Have the ability to provide informed consent for study participation and be willing and able to comply with the prescribed follow-up tests and schedule of evaluations.~Exclusion Criteria:~* Have a classification of Status 1 for cardiac transplantation or consideration for transplantation over the next 3 months.~* Have had a recent myocardial infarction, unstable angina or cardiac revascularization (percutaneous transluminal coronary angioplasty (PTCA), Stent or Coronary Artery Bypass Graft(CABG)) within 40 days of enrollment.~* Have had a recent cerebrovascular accident (CVA) or transient ischemic attack (TIA) within 3 months of enrollment.~* Are allergic to dexamethasone sodium phosphate (DSP).~* Be currently participating in a clinical investigation that includes an active treatment arm.~* Be pregnant or are planning for pregnancy within 6 months following enrollment.~* Have a life expectancy of less than 6 months.~* Be less than 18 years of age.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Promote RF CRT-D (Type: EXPERIMENTAL): Patients with CRT-D device will have the autocapture features of the device tested.
- Current RF ICD (Type: EXPERIMENTAL): Patients with ICD device will have the autocapture features of the device tested.

Based on this trial design, predict the completion outcome and termination type (if applicable).